BPC-157
BPC-157, or Body Protection Compound-157, is a synthetic pentadecapeptide composed of 15 amino acids. It is derived from a naturally occurring protein found in human gastric juice. It is designed to interact with peptide-mediated signaling pathways involved in cellular communication and regulatory processes. Commonly utilized in research settings to study signaling activity, peptide interactions, and biochemical response mechanisms. Supplied by Peptico for research-use only.
All Orders Ship within
24 Business Hours
Free Shipment Protection
Priority Shipment Options Available at Checkout
Format
Lyophilized powder
Approved Exclusively For
Laboratory and Analytical Research
Handling
Utilize appropriate sterile technique and controlled environments during preparation.
Short-Term Storage - Lyophilized Powder Form Only
- For maximum potency, lyophilized materials may generally be stored between 2°C and 8°C (36°F to 46°F) for up to 4 weeks when maintained in their original, sealed lyophilized form.
- Maintain a cool and dry environment.
- Protect from moisture and light.
- Minimize exposure to humidity and temperature fluctuations.
Long-Term Storage - Lyophilized Powder Form Only
- For maximum potency and long-term preservation, lyophilized materials may generally be stored between -20°C and -80°C (-4°F to -112°F) for up to 1 year when preserved in their original, sealed lyophilized form.
- Maintain a cool and dry environment.
- Protect from moisture and light.
- Minimize exposure to humidity and temperature fluctuations.
Important Note:
Storage guidelines apply only to lyophilized material in its original, sealed, and untampered vial.
COA History
All shipped products include a unique batch number printed on the vial label. This batch number corresponds to a third-party Certificate of Analysis tested by an ISO/IEC 17025 accredited laboratory.
The COA attached at the top of this page, along with the COA marked “Current” below, represents the active production batch currently being shipped. This same batch number will appear on the label of your vial.
For previous purchases, please refer to COAs marked “Historical” and match the batch number on your vial to the batch number listed on the corresponding COA.
For a complete record of testing documentation across all products and batches, please visit our COA Vault, which includes both current and historical COAs.
Loading COA history...
Molecular Profile
What is BPC-157?
Scientific compound data sourced from PubChem.
Chemical Structure
PubChem CID 9941957
Type
Chemical compound
PubChem CID
9941957
CAS Number
137525-51-0
Molecular Formula
C62H98N16O22
Molecular Weight
1419.50 g/mol
IUPAC Name
(4S)-4-[(2-aminoacetyl)amino]-5-[(2S)-2-[(2S)-2-[(2S)-2-[[2-[[(2S)-6-amino-1-[(2S)-2-[[(2S)-1-[[(2S)-3-carboxy-1-[[(2S)-3-carboxy-1-[[(2S)-1-[[2-[[(2S)-1-[[(1S)-1-carboxy-2-methylpropyl]amino]-4-methyl-1-oxopentan-2-yl]amino]-2-oxoethyl]amino]-1-oxopropan-2-yl]amino]-1-oxopropan-2-yl]amino]-1-oxopropan-2-yl]amino]-1-oxopropan-2-yl]carbamoyl]pyrrolidin-1-yl]-1-oxohexan-2-yl]amino]-2-oxoethyl]carbamoyl]pyrrolidine-1-carbonyl]pyrrolidine-1-carbonyl]pyrrolidin-1-yl]-5-oxopentanoic acid
InChIKey
HEEWEZGQMLZMFE-RKGINYAYSA-N
Research
Sources & References
API results related to BPC-157.
PubChem
Compound data
BPC-157 compound record
CID: 9941957
Formula: C62H98N16O22 • Molecular weight: 1419.5
View source
PubMed
Scientific paper
Rapid and harmonized analytical workflow for the determination of peptidic and non-peptidic doping agents in dried and liquid blood matrices.
The Analyst
Publication date: 2026 Jun 22
View source
PubMed
Scientific paper
BPC-157 and Its Novel Hybrid Analogs as Inhibitors of Acetylcholinesterase.
International journal of molecular sciences
Publication date: 2026 May 30
View source
PubMed
Scientific paper
Protective effects of BPC 157 in rats with experimentally induced lower extremity ischemia-reperfusion injury.
Scientific reports
Publication date: 2026 May 28
View source
PubMed
Scientific paper
BPC-157 as an Investigational Peptide Therapeutic: Biopharmaceutical Challenges, Formulation Strategies, and Translational Development Barriers.
Pharmaceutics
Publication date: 2026 May 20
View source
PubMed
Scientific paper
Endothelium-Dependent Nitric Oxide-Mediated Vasorelaxant Effects of BPC 157 in Human Internal Mammary Artery.
Journal of clinical medicine
Publication date: 2026 May 2
View source⚠️ IMPORTANT RESEARCH NOTICE
This product is NOT for human consumption.
Supplied strictly for laboratory and analytical research use only, it is not intended to diagnose, treat, cure, or prevent any disease, and must not be used for clinical, veterinary, or therapeutic applications.
All information provided, including referenced research and data, is for educational and scientific context only and should NOT be interpreted as medical guidance.
By purchasing, you confirm that you are a qualified individual or entity operating in accordance with applicable local, state, and federal regulations. All responsibility for handling, use, and compliance rests solely with the purchaser.
